We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

40 hedge funds and large institutions have $52.5M invested in Abeona Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 5

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

39% more capital invested

Capital invested by funds: $37.9M → $52.5M (+$14.7M)

8% more funds holding

Funds holding: 37 → 40 (+3)

0.75% more ownership

Funds ownership: 49.64% → 50.39% (+0.75%)

Holders
40
Holders Change
+3
Holders Change %
+8.11%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
14
Reduced
5
Closed
6
Calls
$491K
Puts
–
Net Calls
+$491K
Net Calls Change
-$57K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$5.63M
2
NCM
Nantahala Capital Management
Connecticut
+$3.39M
3
ACM
AIGH Capital Management
Maryland
+$1.88M
4
Millennium Management
Millennium Management
New York
+$1.14M
5
Citigroup
Citigroup
New York
+$946K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$3.5M
2
Goldman Sachs
Goldman Sachs
New York
-$860K
3
VF
Virtu Financial
New York
-$130K
4
Deutsche Bank
Deutsche Bank
Germany
-$64.6K
5
JGC
J. Goldman & Co
New York
-$10.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$47.1K -$6.79K -1,795 -14%
TRCT
27
Tower Research Capital (TRC)
New York
$43.5K +$39.1K +10,321 New
Group One Trading
28
Group One Trading
Illinois
$42.1K +$37.8K +10,000 New
Morgan Stanley
29
Morgan Stanley
New York
$19.8K – – –
Osaic Holdings
30
Osaic Holdings
Arizona
$11.2K +$246 +65 +2%
UBS Group
31
UBS Group
Switzerland
$4.47K -$167 -44 -4%
HFM
32
Hartford Financial Management
Connecticut
$3.03K – – –
PA
33
Parallel Advisors
California
$1.68K – – –
Wells Fargo
34
Wells Fargo
California
$707 +$151 +40 +31%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$243 – – –
TC
36
Truvestments Capital
Florida
$215 – – –
JP Morgan Chase
37
JP Morgan Chase
New York
$59 – – –
CT
38
Cambridge Trust
Massachusetts
$55 – – –
DM
39
Deerfield Management
New York
– -$3.5M -869,565 Closed
Goldman Sachs
40
Goldman Sachs
New York
– -$860K -213,282 Closed
VF
41
Virtu Financial
New York
– -$130K -32,171 Closed
Deutsche Bank
42
Deutsche Bank
Germany
– -$64.6K -16,022 Closed
Fidelity Investments
43
Fidelity Investments
Massachusetts
– -$64 -16 Closed
2L
44
25 LLC
Missouri
– -$20 -5 Closed
HCM
45
Highlander Capital Management
New Jersey
– +$4 +1 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
– +$26 +7 New
1
2

ABEO Hedge Fund Activity: Q3 2023 in Review

40 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q3 2023, worth a combined $52.5M — up 39% from $37.9M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ABEO positions and 6 closed out — a net gain of 3 holders — while 14 added to existing stakes and 5 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $5.63M. The largest seller was Deerfield Management, exiting entirely with an estimated $3.5M sold.

  • 40 institutional investors held Abeona Therapeutics (ABEO) as of Q3 2023, up from 37 in Q2 2023.
  • Funds reported $52.5M of Abeona Therapeutics stock for Q3 2023, up 39% quarter-over-quarter.
  • 9 funds opened new Abeona Therapeutics positions in Q3 2023 and 6 closed out, a net change of +3 holders.
  • The largest Abeona Therapeutics buyer in Q3 2023 was Adage Capital Partners, an estimated $5.63M added.
  • The largest Abeona Therapeutics seller in Q3 2023 was Deerfield Management, an estimated $3.5M sold.

Based on aggregated 13F filings for Q3 2023.